Page 2 - Johnm Evans News Today

Beam Therapeutics (NASDAQ:BEAM – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.69) by $2.42, Briefing.com reports. The company had revenue of $316.20 million for the quarter, compared to analysts’ expectations of $34.16 million. Beam Therapeutics had […]

Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a note issued to investors on Tuesday, RTT News reports. They presently have a $57.00 price objective on the stock, up from their prior price objective of $48.00. Wedbush’s price objective would suggest a potential upside of […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) fell 8.9% during mid-day trading on Tuesday . The company traded as low as $30.30 and last traded at $30.44. 405,654 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 1,195,352 shares. The stock had previously closed at $33.40. Analysts […]

Clarius Group LLC raised its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 115.6% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 60,615 shares of the company’s stock after purchasing an additional 32,504 shares during the quarter. Clarius Group […]

YEREVAN, JUNE 22, ARMENPRESS. The Tom Lantos Human Rights Commission of the U.S. Congress has held a hearing on Safeguarding the People of Nagorno-Karabakh.

YEREVAN, JUNE 22, ARMENPRESS. The Tom Lantos Human Rights Commission of the U.S. Congress has held a hearing on Safeguarding the People of Nagorno-Karabakh.

YEREVAN, JUNE 22, ARMENPRESS. The Tom Lantos Human Rights Commission of the U.S. Congress has held a hearing on Safeguarding the People of Nagorno-Karabakh.

YEREVAN, JUNE 22, ARMENPRESS. The Tom Lantos Human Rights Commission of the U.S. Congress has held a hearing on Safeguarding the People of Nagorno-Karabakh.

Nikko Asset Management Americas Inc. boosted its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 31.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 673,690 shares of the company’s stock after acquiring an additional 162,759 shares during the period. […]

Sectoral Asset Management Inc. lessened its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 3.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,500 shares of the company’s stock after selling 2,200 shares during the quarter. Sectoral Asset Management […]